Prevalence of Primary Biliary Cirrhosis-Autoimmune Hepatitis Overlap Syndrome

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 7, 2011, Pages 609-612

  Bonder, Alan ^a   Retana, Alexandra ^a   Winston, Diana M ^a   Leung, John ^a   Kaplan, Marshall M ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Diagnosis; IgG; Liver Disease; Therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; COLCHICINE; IMMUNOGLOBULIN G; METHOTREXATE; PREDNISONE; URSODEOXYCHOLIC ACID;

ADD ON THERAPY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIMARY BILIARY CIRRHOSIS CHRONIC AUTOIMMUNE HEPATITIS OVERLAP SYNDROME; SYNDROME;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AUTOANTIBODIES; BOSTON; ENZYMES; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 79959329150     PISSN: 15423565     EISSN: 15423565     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.03.019     Document Type: Article

References (21)

1. Boberg K.M., Chapman R.W., Hirschfield G.M., et al. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011, 54:374-385.
2. Chazouillères O., Wendum D., Serfaty L., et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998, 28:296-301.
3. Kuiper E.M.M., Zondervan P.E., van Buuren H.R. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2010, 8:530-534.
4. Chazouillères O., Wendum D., Serfaty L., et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 2006, 44:400-406.
5. Czaja A.J. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998, 28:360-365.
6. Czaja A.J. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008, 48:1540-1548.
7. Neuhauser M., Bjornsson E., Treeprasertsuk S., et al. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol 2010, 105:345-353.
8. Talwalkar J.A., Keach J.C., Angulo P., et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol 2002, 97:1191-1197.
9. Poupon R., Chazouilleres O., Corpechot C., et al. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. Hepatology 2006, 44:85-90.
10. Al-Chalabi T., Portmann B.C., Bernal W., et al. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Aliment Pharmacol Ther 2008, 28:209-220.
11. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology 1996, 24:289-293.
12. Vallone T.M., Ditelberg J., Kaplan M.M. Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Dig Dis Sci 2005, 50:167-170.
13. Kaplan M.M., Bonder A., Ruthazer R., et al. Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid. Dig Dis Sci 2010, 55:3207-3217.
14. Burak K.W., Urbanski S.J., Swain M.G. Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate. J Hepatol 1998, 29:990-993.
15. Pratt D.S., Kaplan M.M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000, 342:1266-1271.
16. Tassoni J.P., Kaplan M.M. Rapidly progressive liver failure in a 65-year-old woman. Gastroenterology 1991, 100:1462-1468.
17. Leuschner M., Maier K.P., Schlichting J., et al. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Gastroenterology 1999, 117:918-925.
18. Rautiainen H., Kärkkäinen P., Karvonen A., et al. Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial. Hepatology 2005, 41:747-752.
19. Rabahi N., Chrétien Y., Gaouar F., et al. Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone. Gastroenterol Clin Biol 2010, 34:283-287.
20. Lindor K.D., Gershwin M.E., Poupon R., et al. Primary biliary cirrhosis. Hepatology 2009, 50:291-308.
21. Silveira M.G., Talwalkar J.A., Lindor K.D., et al. Recurrent primary biliary cirrhosis after liver transplantation. Am J Transplant 2010, 10:720-726.